Epidemiology of candidemia

Revista Iberoamericana de Micologia

Volumn 17, Issue 3, 2000, Pages 73-81

  Sandven, P ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BACTEREMIA; CANADA; CANDIDA; IMMUNE DEFICIENCY; MEDICAL CARE; METHODOLOGY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SPECIES DIFFERENTIATION; UNITED STATES; YEAST;

EID: 0033667453     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (86)

1. International conference for the development of a consensus on the management and prevention of severe Candida infections
2. The clinical significance of positive blood cultures in the 1990s: A prospective, comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults
3. Disseminated candidiasis in surgical patients
4. Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis: Disseminated versus single organ infection
5. The importance of blood volume cultured on detection of bacteraemia
6. Controlled evaluation of the volume of blood cultured in detection of bacteremia and fungemia
7. Comparison of Du Pont isolator and Roche Septi-Chek for detection of fungemia
8. Comparison of the lysis-centrifugation and agitated biphasic blood culture systems for detection of fungemia
9. Epidemiology of nosocomial fungal infections
10. National epidemiology of mycoses survey: A multicenter study of strain variation and antifungal susceptibility among isolates of Candida species
11. Bacteremia at Boston city hospital: Occurrence and mortality during 12 selected years (1935-1972), with special reference to hospital-acquired cases
12. Fungemia in a cancer hospital: Changing frequency, earlier onset, and results of therapy
13. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: Frequency, characteristics, and evaluation of factors influencing outcome
14. Detection of yeasts and filamentous fungi in blood cultures during a 10-year period (1972 to 1981)
15. Analysis of 281,797 consecutive blood cultures performed over an eight-year period: Trends in microorganisms isolated and the value of anaerobic culture of blood
16. Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths
17. Candidemia in a tertiary care hospital: Epidemiology, risk factors, and predictors of mortality
18. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990
19. Epidemiology of nosocomial fungal infections, with emphasis on Candida species
20. Candidemia in a Canadian tertiary care hospital from 1976 to 1996
21. Septicemia in 980 patients at a university hospital in Bedin: Prospective studies during 4 selected years between 1979 and 1989
22. Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch university hospitals
23. Longitudinal 10-year prospective survey of fungaemia in Slovak Republic: Trends in etiology in 310 episodes. Slovak fungaemia study group
24. Constant low rate of fungemia in Norway, 1991 to 1996
25. Fungemia. Case records from Ulleval hospital
26. Bloodstream infections at a Norwegian university hospital, 1974-979 and 1988-1989: Changing etiology, clinical features, and outcome
27. Fungemia in a university hospital 1984-1988. Clinical and mycological characteristics
28. Fungemia: An increasing problem in a Danish university hospital 1989 to 1994
29. Candidaemia: A 10-year study in an indian teaching hospital
30. Antifungal susceptibility pattern of non-albicans Candida species and distribution of species isolated from candidaemia cases over a 5 year period
31. Nosocomial candidemia in a university hospital in Taiwan
32. Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period
33. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989
34. The epidemiology of hematogenous candidiasis caused by different Candida species
35. Candidemia in cancer patients: A prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)
36. Changes in clinical features of fungemia in a Japanese University Hospital over a 12-year period
37. Epidemiology of Candidemia - A nationwide survey in Israel
38. Nosocomial bloodstream infections in United States hospitals: A three- year analysis
39. National surveillance of nosocomial blood stream infection due to Candida albicans: Frequency of occurrence and antifungal susceptibility in the SCOPE program
40. Candida norvegensis: A fluconazole-resistant species
41. Candida sepsis: Implications of polymicrobial blood-borne infection
42. Bloodstream infections due to Candida species: SENTRY antimicrobial survei llance program in North America and Latin America, 1997-1998
43. The epidemiology of candidemia in two United States cities: Results of a population-based active surveillance
44. Candidemia: Current epidemiologic characteristics and a longerm follow-up of the survivors
45. National epidemiology of mycoses survey (NEMIS): Variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units
46. The changing face of candidemia: Emergence of non-Candida albicans species and antifungal resistance
47. Trends and sources of nosocomial fungaemia
48. Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients. Canadian Candidemia Study Group
49. Candidemia at selected Canadian sites: Results from the Fungal Disease Registry, 1992-1994. Fungal Disease Registry of the Canadian Infectious Disease Society
50. Epidemiology of nosocomial bloodstream infections in Belgium, 1992-1996
51. Pilze als sepsiserreger -Ergebnisse einer multizentrischen studie
52. Candida fungemia
53. Isolation of fungi in blood cultures. A review of fungal infections in the western part of Sweden 1970-1982
54. Etude d'une collection norvegienne de levures
55. Candida norvegensis peritonitis and invasive disease in a patient on continuous ambulatory peritoneal dialysis
56. Invasive Candida norvegensis infection in immunocompromised patients
57. Isolation of Candida norvegensis from clinical specimens: Four case reports
58. Rising incidence of Candida parapsitosis fungemia in patients with hematologic malignancies: Clinical aspects, predisposing factors, and differential pathogenicity of the causative strains
59. A multicenter study on fungemia caused by yeasts in Spain (April-June, 1997)
60. Fungemia 1973-1983. Analysis of 67 patients
61. Candidemia in non-neutropenic critically ill patients: Analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU
62. Analysis of 84 cases with fungemia
63. Microbiological and clinical study of fungemia between 1981 and 1992
64. High incidence of non-albicans candidemia despite rare use of azoles
65. High rate of non-albicans candidemia in Brazilian tertiary care hospitals
66. Nosocomial fungaemia: A 2-year prospective study
67. Fungemia in cancer patients in Brazil: Predominance of non-albicans species
68. Multicountry candidemia survey
69. Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality
70. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole
71. Changing etiology of nosocomial bacteremia and fungemia and other hospital-acquired infections
72. Hospitalacquired fungemia. Its natural course and clinical significance
73. Fungal sepsis in surgical patients
74. Radiometric detection of yeasts in blood cultures of cancer patients
75. Relative frequency of nosocomial pathogens at a university hospital during the decade 1980 to 1989
76. Nosocomial fungemia in a large community teaching hospital
77. National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: Frequency of occurrence and antifungal susceptibility in the SCOPE Program
78. Two thousands seven hundred and thirty nine episodes of bacteremia in the county of Northern Jutland 1996-1998. Presentation of a regional clinical database
79. Description of 165 episodes of fungemia: A multicenter study
80. Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998
81. International surveillance of blood stream infections due to Candida species in the European SENTRY program: Species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents
82. Secular trends in the epidemiology of nosocomial fungal infections at a teaching hospital in Taiwan, 1981 to 1993
83. International surveillance of bloodstream infections due to Candida species: Frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY program. The SENTRY Participant Group
84. Fungal sepsis in surgical patients
85. Retrospective study of candidemia in patients with hematological malignancies. Clinical features, risk factors and outcome of 76 episodes
86. The incidence of hospital fungal infections - Yeast fungaemia